A structured review published in Cureus on October 29, 2026 assesses how far the world has come in eliminating viral hepatitis B and C, and what stands in the way of the World Health Organization's 2030 targets. According to Cureus, the paper covers epidemiology, inequities and gaps in service delivery.
The review is framed around the WHO elimination goals for the two viruses, which together account for most of the global viral hepatitis burden. Rather than reporting new trial data, it draws together existing evidence on where the diseases are concentrated and how progress is tracked.
According to Cureus, the authors also examine inequities in who is affected and who receives care. Service delivery gaps form the third focus of the review, pointing to weaknesses in how prevention, testing and treatment reach the people who need them.
The paper's title places the burden and elimination progress side by side, suggesting the review weighs advances against the scale of the remaining task. No further findings or figures from the article were available at the time of writing.
The 2030 deadline set by the WHO gives the review a fixed benchmark. What to watch next: whether subsequent research and country-level reporting show the service delivery gaps identified here narrowing as that date approaches.
